Healthy Inc > Blog > cardioselective beta blocker
Posted on:

What are Metoprolol Tartrate 50 mg tablets used for?

In the pharmaceutical industry, Metoprolol Tartrate 50 mg is a classic selective beta-blocker targeting the -adrenergic receptors. As a pharmacist and manufacturer, I classify this as an “immediate-release” cardioselective agent. While its brother, Metoprolol Succinate, is designed for 24-hour extended release, the Tartrate version is typically administered twice daily for rapid and precise control of heart rate and blood pressure.

Primary Clinical Uses

  • Hypertension (High Blood Pressure): Used to lower blood pressure, thereby reducing the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.

  • Angina Pectoris: Used for the long-term prophylaxis of chest pain by reducing the oxygen demand of the heart.

  • Post-Myocardial Infarction: Administered to stable patients after a heart attack to reduce cardiovascular mortality.

  • Arrhythmias: Effective in controlling ventricular rate in patients with atrial fibrillation or supraventricular tachycardia.

  • Migraine Prophylaxis (Off-label): Frequently prescribed to reduce the frequency and severity of migraine attacks.

Mechanism of Action:  Selectivity

Metoprolol Tartrate works by competing with adrenergic neurotransmitters (like adrenaline) for binding sites.

Selective Blockade: At standard doses (like 50 mg), it preferentially blocks  receptors located chiefly in the heart muscle.

Negative Inotropic & Chronotropic Effects: It decreases the heart rate (chronotropic) and the force of contraction (inotropic).

Cardiac Output: By slowing the heart and reducing the force, it lowers cardiac output and blood pressure, giving the heart a “rest.”

Renin Inhibition: It also reduces the release of renin from the kidneys, further interfering with the blood-pressure-raising RAAS pathway.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Metoprolol Tartrate 50 mg is a high-volume cardiovascular staple:

  • Tartrate vs. Succinate (The USP): On your digital platforms, it is vital to distinguish between the two. Tartrate is Immediate Release (IR), while Succinate is Extended Release (ER/XL). B2B buyers often look for Tartrate for acute hospital settings or specific twice-a-day titration needs.

  • Scored Tablets: Most 50 mg tablets are produced with a break-line (score). As a WHO-GMP manufacturer, we ensure “Content Uniformity” across the score line, allowing patients to accurately split the tablet into two 25 mg doses if prescribed.

  • Stability & Sensitivity: Metoprolol is sensitive to light and moisture. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions.

  • Dossier Support: Our Mumbai facility provides full CTD/eCTD Dossiers and bioequivalence data against the innovator (Lopressor) to support your firm’s international registrations.

Metoprolol Tablets

Posted on:

What is an atenolol tablet good for?

In the pharmaceutical industry, Atenolol tablets (typically 25 mg, 50 mg, and 100 mg) are a foundational Cardioselective Beta-Blocker ($\beta_1$-selective). As a pharmacist, I view Atenolol as a “precision tool” for cardiovascular management because it specifically targets the heart’s receptors while minimizing the respiratory side effects often seen with older, non-selective beta-blockers.

Primary Clinical Uses

  • Hypertension (High Blood Pressure): It is used to lower blood pressure, which helps prevent long-term complications such as strokes, heart failure, and kidney problems.

  • Angina Pectoris: Indicated for the long-term management of chest pain by reducing the oxygen demand of the heart muscle during physical activity or stress.

  • Acute Myocardial Infarction: Administered to stable patients post-heart attack to reduce cardiovascular mortality and the risk of re-infarction.

  • Cardiac Arrhythmias: Used to control heart rate in conditions like atrial fibrillation or supraventricular tachycardia.

Mechanism of Action

Atenolol is a competitive antagonist of $\beta_1$-adrenergic receptors, which are primarily located in the heart. By blocking the effects of epinephrine (adrenaline) and norepinephrine, it:

Reduces Heart Rate (Negative Chronotropic effect): Slows the resting and exercise heart rate.

Decreases Contractility (Negative Inotropic effect): Reduces the force with which the heart muscle pumps.

Lowers Blood Pressure: By reducing cardiac output and inhibiting the release of renin from the kidneys.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Atenolol is a high-demand, stable molecule that is a staple for B2B export portfolios:

  • Cardioselectivity Standards: As a WHO-GMP manufacturer, we ensure that our formulation maintains strict $\beta_1$ selectivity. This is a critical selling point for doctors who need to treat hypertensive patients with mild underlying respiratory issues (where non-selective blockers like Propranolol are contraindicated).

  • Stability & Shelf Life: Atenolol is a chemically robust molecule. We provide it in various packaging formats (blister/strip) designed to withstand the climatic conditions of Zone IVb (hot and humid), ensuring a reliable 36-month shelf life for our export partners.

  • Global Market Demand: Given that cardiovascular disease is a leading global health concern, Atenolol remains a high-volume item for international tenders and B2B marketplaces in Africa, the Middle East, and Southeast Asia.

  • Regulatory Documentation: We provide full CTD/eCTD Dossiers and Comparative Dissolution Profiles to ensure our partners can easily register the product with their local health authorities (e.g., NAFDAC, PPB, TFDA).

 

Add to cart